sftd
GeneSearch™ BLN Assay: First Molecular-based Lab Test for Metastatic Breast Cancer Detection, FDA-Approved
Filed in archive Diagnostics , News by Gloria Gamat on July 17, 2007
GeneSearch_BLN_assay_kit.jpg
The US FDA has just approved the first molecular-based laboratory test for detecting metastasized breast cancer: GeneSearch™ Breast Lymph Node (BLN) Assay.

Manufactured by Veridex (a Johnson & Johnson Company), GeneSearch™ BLN Assay detects molecules that are abundant in breast tissue but scarce in a normal lymph node.

The presence or absence of breast cancer cells in underarm lymph nodes is a powerful predictor of whether the cancer has spread and is used to help decide appropriate therapy for a woman with metastatic breast cancer.

Lymph nodes are part of the system that helps protect the body against infection. The first lymph node that filters fluid from the breast is called the "sentinel node," because that is where breast cancer cells are likely to spread first.


Find more details from the full report.



Permalink: GeneSearch™ BLN Assay: First Molecular-based Lab Test for Metastatic Breast Cancer Detection, FDA-Approved
Tags: GeneSearch™  Breast  Lymph  Node  BLN  Assay  metastatic  breast  cancer  contact  breast+cancer 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/81369
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for GeneSearch™ BLN Assay: First Molecular-based Lab Test for Metastatic Breast Cancer Detection, FDA-Approved:

  • Currently 8.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.00 out of 2 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!